Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine

被引：0
|
作者：
Janne T. Backman
Marika T. Schröder
Pertti J. Neuvonen
机构：
[1] University of Helsinki and Helsinki University Central Hospital,Department of Clinical Pharmacology
[2] University of Helsinki,Department of Clinical Pharmacology
来源：
European Journal of Clinical Pharmacology | 2008年 / 64卷
关键词：
Gender; Smoking; Tizanidine; CYP1A2; Caffeine test;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：17 / 24
页数：7
相关论文
共 50 条
  • [41] Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics
    Saiz-Rodriguez, Miriam
    Ochoa, Dolores
    Belmonte, Carmen
    Roman, Manuel
    Vieira de Lara, Danilo
    Zubiaur, Pablo
    Koller, Dora
    Mejia, Gina
    Abad-Santos, Francisco
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (04) : 522 - 531
  • [42] Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates
    Wang, Xin
    Lee, Wayne Y. W.
    Or, Penelope M. Y.
    Yeung, John H. K.
    PHYTOMEDICINE, 2009, 16 (08) : 712 - 725
  • [43] Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers
    Peng, WX
    Li, HD
    Zhou, HH
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (03) : 237 - 241
  • [44] Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers
    Wen-Xing Peng
    Huan-De Li
    Hong-Hao Zhou
    European Journal of Clinical Pharmacology, 2003, 59 : 237 - 241
  • [45] CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking
    Rodenburg, Eline M.
    Eijgelsheim, Mark
    Geleijnse, Johanna M.
    Amin, Najaf
    van Duijn, Cornelia M.
    Hofman, Albert
    Uitterlinden, Andre G.
    Stricker, Bruno H.
    Visser, Loes E.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2012, 96 (01): : 182 - 187
  • [46] Heritability of Caffeine Metabolism: Environmental Effects Masking Genetic Effects on CYP1A2 Activity but Not on NAT2
    Matthaei, J.
    Tzvetkov, M. V.
    Strube, J.
    Sehrt, D.
    Sachse-Seeboth, C.
    Hjelmborg, J. B.
    Moller, S.
    Halekoh, U.
    Hofmann, U.
    Schwab, M.
    Kerb, R.
    Brockmoeller, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (06) : 606 - 616
  • [47] Effects of ellagic acid on CYP2E1, CYP1A1, CYP1A2, NQO1 and GSTMu enzymes in rat
    Sen, A.
    Celik, G.
    Semiz, A.
    Karakurt, S.
    Adali, O.
    FEBS JOURNAL, 2011, 278 : 241 - 241
  • [48] Inducibility of CYP1A2 by orneprazole in vivo related to the genetic polymorphism of CYP1A2
    Han, XM
    Ouyang, DS
    Chen, XP
    Shu, Y
    Jiang, CH
    Tan, ZR
    Zhou, HH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (05) : 540 - 543
  • [49] 3-METHYLCHOLANTHRENE AND PYRIDINE EFFECTS ON CYP1A1 AND CYP1A2 EXPRESSION IN RAT RENAL TISSUE
    KIM, H
    REDDY, S
    NOVAK, RF
    DRUG METABOLISM AND DISPOSITION, 1995, 23 (08) : 818 - 824
  • [50] An in vivo comparison of paroxetine and fluvoxamine: Effects on CYP1A2 and CYP2D6 activities.
    Ozdemir, V
    Naranjo, CA
    Shulman, RW
    Herrmann, N
    Sellers, EM
    Kalow, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII47 - PII47
12345